Roberto Bolli

Active 1983–2024

195
Papers
39,220
Citations
114
h-index
194
i10-index

Citations

Citations per year for Roberto Bolli1970: 1 citations1971: 1 citations1973: 2 citations1978: 1 citations1985: 2 citations1986: 6 citations1987: 10 citations1988: 38 citations1989: 70 citations1990: 71 citations1991: 87 citations1992: 48 citations1993: 71 citations1994: 73 citations1995: 84 citations1996: 98 citations1997: 135 citations1998: 218 citations1999: 257 citations2000: 286 citations2001: 323 citations2002: 403 citations2003: 391 citations2004: 386 citations2005: 315 citations2006: 394 citations2007: 396 citations2008: 379 citations2009: 417 citations2010: 387 citations2011: 371 citations2012: 327 citations2013: 290 citations2014: 314 citations2015: 249 citations2016: 250 citations2017: 197 citations2018: 303 citations2019: 623 citations2020: 557 citations2021: 588 citations2022: 357 citations2023: 280 citations2024: 399 citations2025: 175 citations1972: no citations, so this year is not shown1974–1977: no citations, so these years are not shown1979–1984: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 3,196 citing papers, 35.1% of this breakdownChina: 801 citing papers, 8.8% of this breakdownUnited Kingdom: 593 citing papers, 6.5% of this breakdownGermany: 536 citing papers, 5.9% of this breakdownItaly: 476 citing papers, 5.2% of this breakdownJapan: 316 citing papers, 3.5% of this breakdownCanada: 299 citing papers, 3.3% of this breakdownNetherlands: 222 citing papers, 2.4% of this breakdownFrance: 216 citing papers, 2.4% of this breakdownAustralia: 160 citing papers, 1.8% of this breakdownSpain: 152 citing papers, 1.7% of this breakdownSouth Korea: 120 citing papers, 1.3% of this breakdown
0%35.1%Other 22.1%

Fields

  • Medicine61.5%
  • Biochemistry, Genetics and Molecular Biology29.5%
  • Neuroscience2%
  • Immunology and Microbiology2%
  • Engineering1.6%
  • Nursing0.9%
  • Other2.5%

Topics

  • Cardiac Ischemia and Reperfusion8.5%
  • Tissue Engineering and Regenerative Medicine5.2%
  • Cardiac Fibrosis and Remodeling3.7%
  • Mesenchymal stem cell research3.3%
  • Congenital heart defects research2.8%
  • Cardiac Arrest and Resuscitation2.6%
  • Other73.9%

Coauthors

All papers

Open in search
  1. Guidelines for experimental models of myocardial ischemia and infarction

    Authors: , , , , , , , , , , , , , , , , , , , - American Journal of Physiology-Heart and Circulatory Physiology 2018 cited by 511

  2. A Phase II study of autologous mesenchymal stromal cells and c‐kit positive cardiac cells, alone or in combination, in patients with ischaemic heart failure: the CCTRN CONCERT‐HF trial

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Michelle Cohen, Lara M. Simpson, David Aguilar, Cătălin Loghin, Lem Moyé, Ray F. Ebert, Barry R. Davis, Robert D. Simari - European Journal of Heart Failure 2021 cited by 166

  3. Cardiomyocyte Regeneration: A Consensus Statement.

    Authors: , , , , , , , , , , , , , , , , , , - Circulation 2017 cited by 498

  4. Basic and Translational Research in Cardiac Repair and Regeneration

    Authors: , , , , , , , , - Journal of the American College of Cardiology 2021 cited by 107

  5. Transient Cell Cycle Induction in Cardiomyocytes to Treat Subacute Ischemic Heart Failure

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , - Circulation 2022 cited by 66

  6. Cell Therapy for Heart Failure

    Authors: , - Circulation Research 2013 cited by 542

  7. New Paradigms in Cell Therapy

    Authors: , , - Circulation Research 2018 cited by 173

  8. Vascular endothelial growth factor in heart failure

    Authors: , , , - Nature Reviews Cardiology 2013 cited by 234

  9. Molecular and Cellular Mechanisms of Myocardial Stunning

    Authors: , - Physiological Reviews 1999 cited by 1,031

  10. Cell therapy in patients with heart failure: a comprehensive review and emerging concepts

    Authors: , , , - Cardiovascular Research 2021 cited by 108

  11. Role of the JAK–STAT Pathway in Protection Against Myocardial Ischemia/Reperfusion Injury

    Authors: , , - Trends in Cardiovascular Medicine 2003 cited by 234

  12. Clinical Studies of Cell Therapy in Cardiovascular Medicine

    Authors: , , - Circulation Research 2018 cited by 177

  13. Sodium-Hydrogen Exchange Inhibition by Cariporide to Reduce the Risk of Ischemic Cardiac Events in Patients Undergoing Coronary Artery Bypass Grafting: Results of the EXPEDITION Study

    Authors: , , , , , , , , , , , , , - The Annals of Thoracic Surgery 2008 cited by 266

  14. The NHLBI-Sponsored Consortium for preclinicAl assESsment of cARdioprotective Therapies (CAESAR)

    Authors: , , , , , , , , , , , , , , , , , , , , - Circulation Research 2014 cited by 186

  15. Physiological Biomimetic Culture System for Pig and Human Heart Slices

    Authors: , , , , , , , , , , , , , , , , , , , - Circulation Research 2019 cited by 103

  16. Concise Review: Review and Perspective of Cell Dosage and Routes of Administration From Preclinical and Clinical Studies of Stem Cell Therapy for Heart Disease

    Authors: , , , , , , , , , , , , - Stem Cells Translational Medicine 2015 cited by 166

  17. Cardioprotective and Antiapoptotic Effects of Heme Oxygenase-1 in the Failing Heart

    Authors: , , , , , , , , , , , , , , , , - Circulation 2010 cited by 247

  18. Molecular and Cellular Mechanisms Associated with Effects of Molecular Hydrogen in Cardiovascular and Central Nervous Systems

    Authors: , , , , , - Antioxidants 2020 cited by 63

  19. Allogeneic Mesenchymal Cell Therapy in Anthracycline-Induced Cardiomyopathy Heart Failure Patients

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Lem Moyé, Ray F. Ebert, Barry R. Davis, Robert D. Simari - JACC CardioOncology 2020 cited by 50

  20. c-kit+ Cardiac Stem Cells Alleviate Post-Myocardial Infarction Left Ventricular Dysfunction Despite Poor Engraftment and Negligible Retention in the Recipient Heart

    Authors: , , , , , , , , , , , - PLoS ONE 2014 cited by 198

  21. Global position paper on cardiovascular regenerative medicine

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Kai C. Wollert, Wayne Balkan, Roberto Bolli, Steven A. J. Chamuleau, Dominique Charron, María Eugenia Fernández‐Santos, Valentı́n Fuster, Georg Goliasch, Mariann Gyöngyösi, Joshua M. Hare, Thomas F. Lüscher, Bryon A. Tompkins, Johannes Winkler, Antoni Bayés‐Genís, Timothy D. Henry, Doris A. Taylor, Andreu M. Climent, Amir Lerman, Beatriz Pelacho, Felipe Prósper, Ricardo Sanz‐Ruiz, Emerson C. Perin, Giulio Pompilio, Bernard J. Gersh, Jozef Bartúnek, Eric Duckers, Péter Ferdinandy, Stefan Janssens, Douglas W. Losordo, Pedro L. Sánchez, Warren Sherman, Wojtek Wojakowski, Andreas M. Zeiher, Jens Kastrup, Jérôme Roncalli, Anthony Mathur, Filippo Crea, Domenico Amario, Thomas J. Povsic, Jay H. Traverse, Seppo Ylä‐Herttuala - European Heart Journal 2017 cited by 168

  22. Heart slice culture system reliably demonstrates clinical drug-related cardiotoxicity

    Authors: , , , , , , , , , , , , , , , , , - Toxicology and Applied Pharmacology 2020 cited by 35

  23. The Late Phase of Preconditioning

    Authors: - Circulation Research 2000 cited by 750

  24. Cyclooxygenase-2 mediates the cardioprotective effects of the late phase of ischemic preconditioning in conscious rabbits

    Authors: , , , , , , , - National Academy of Sciences, Proceedings of the National Academy of Sciences 2000 cited by 383